X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3390) 3390
Book Review (716) 716
Publication (238) 238
Book / eBook (111) 111
Book Chapter (101) 101
Newsletter (30) 30
Newspaper Article (27) 27
Transcript (8) 8
Conference Proceeding (7) 7
Dissertation (4) 4
Trade Publication Article (4) 4
Reference (3) 3
Web Resource (3) 3
Journal / eJournal (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2713) 2713
humans (2344) 2344
cytogenetics (1883) 1883
female (1236) 1236
male (1227) 1227
adult (965) 965
middle aged (868) 868
hematology (857) 857
oncology (854) 854
aged (623) 623
cytogenetic analysis (618) 618
analysis (552) 552
cancer (546) 546
genetics & heredity (525) 525
chromosome aberrations (501) 501
prognosis (445) 445
chronic myelogenous leukemia (442) 442
research (393) 393
leukemia (386) 386
chromosomes (384) 384
adolescent (380) 380
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (344) 344
animals (337) 337
treatment outcome (336) 336
in situ hybridization, fluorescence (329) 329
imatinib mesylate (328) 328
chronic myeloid leukemia (307) 307
genetic aspects (298) 298
toxicology (292) 292
diagnosis (284) 284
in-situ hybridization (284) 284
young adult (283) 283
antineoplastic agents - therapeutic use (276) 276
mutation (274) 274
aged, 80 and over (273) 273
genetics (261) 261
care and treatment (260) 260
child (250) 250
pyrimidines - therapeutic use (235) 235
leukemia, myelogenous, chronic, bcr-abl positive - genetics (232) 232
benzamides (231) 231
chronic myeloid-leukemia (229) 229
minimal residual disease (226) 226
therapy (220) 220
fish (218) 218
pathology (215) 215
environmental sciences (212) 212
imatinib (212) 212
piperazines - therapeutic use (210) 210
hematology, oncology and palliative medicine (209) 209
risk factors (207) 207
cell biology (206) 206
karyotyping (202) 202
lymphocytes (201) 201
medicine & public health (200) 200
genes (199) 199
transplantation (198) 198
acute myeloid-leukemia (195) 195
biotechnology & applied microbiology (192) 192
health aspects (188) 188
dna (181) 181
stem cells (178) 178
genetic research (177) 177
cells (173) 173
chemotherapy (173) 173
gastroenterology & hepatology (172) 172
medicine (172) 172
survival (171) 171
protein kinase inhibitors - therapeutic use (170) 170
fusion proteins, bcr-abl - genetics (168) 168
cytogenetic responses (167) 167
bone marrow (163) 163
child, preschool (163) 163
acute lymphoblastic-leukemia (162) 162
polymerase chain reaction (162) 162
bcr-abl (160) 160
genomics (160) 160
risk (160) 160
follow-up (159) 159
biology (156) 156
dna damage (156) 156
gene expression (156) 156
fluorescence (155) 155
leukemia, myeloid, acute - genetics (155) 155
follow-up studies (152) 152
acute myeloid leukemia (151) 151
comparative genomic hybridization (151) 151
abridged index medicus (149) 149
fluorescence in situ hybridization (149) 149
life sciences (145) 145
time factors (145) 145
retrospective studies (144) 144
patients (143) 143
flow cytometry (141) 141
tumors (141) 141
chronic-phase (139) 139
gastroenterology and hepatology (139) 139
remission induction (138) 138
research article (138) 138
interferon-alpha (136) 136
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (77) 77
UTL at Downsview - May be requested (11) 11
UofT at Mississauga - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Online Resources - Online (6) 6
UofT at Scarborough - Stacks (5) 5
Earth Sciences (Noranda) - Stacks (4) 4
Royal Ontario Museum - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Periodical Stacks (2) 2
Gerstein Science - Bindery (1) 1
Regis College - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - May be requested (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3601) 3601
Russian (32) 32
German (13) 13
Portuguese (9) 9
Chinese (6) 6
Spanish (6) 6
French (4) 4
Czech (3) 3
Polish (3) 3
Slovenian (3) 3
Arabic (2) 2
Croatian (2) 2
Italian (1) 1
Lithuanian (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 07/2017, Volume 92, Issue 4, pp. 315 - 318
BackgroundCD19 is a B-cell specific marker, expressed on all stages of B-lymphocytes including plasma cells. It is widely used in the flow cytometric... 
Flow cytometric immunophenotyping (FCI) | CD19 | B‐cell acute lymphoblastic leukemia | B-cell acute lymphoblastic leukemia | CD20 EXPRESSION | CELLS | FLOW-CYTOMETRY | MEDICAL LABORATORY TECHNOLOGY | PATHOLOGY | MINIMAL RESIDUAL DISEASE | ANTIGEN | Antigens, CD - immunology | Gene Expression | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Antibodies - chemistry | Down-Regulation | Humans | Bone Marrow Cells - pathology | Child, Preschool | Antigens, CD19 - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Antigens, CD - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | B-Lymphocytes - immunology | Flow Cytometry | Bone Marrow Cells - immunology | Karyotyping | Adult | Female | Immunophenotyping - methods | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | Antigens, CD19 - immunology | Oncology, Experimental | Analysis | Cytogenetics | Acute lymphocytic leukemia | Diagnosis | Research | Cytochemistry | Cancer | Flow cytometry | Laboratories | Leukemia | Assaying | Lymphocytes | Precursors | Peripheral blood | Bone marrow | Gating | Monitoring | Translocation | CD34 antigen | CD19 antigen | Acute lymphatic leukemia | Markers | Color | Lymphatic leukemia | CD22 antigen | Cytometry | Lymphocytes B | Morphology | Plasma cells | CD20 antigen | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 03/2011, Volume 117, Issue 6, pp. 1245 - 1252
BACKGROUND: The current study was conducted to compare simultaneously obtained bone marrow (BM) cytogenetics (CTG), peripheral blood (PB) and BM fluorescence... 
polymerase chain reaction (PCR) | monitoring | blood | fluorescence in situ hybridization (FISH) | chronic myeloid leukemia (CML) | CHRONIC MYELOGENOUS LEUKEMIA | CHRONIC-PHASE | BCR-ABL | IN-SITU HYBRIDIZATION | RESIDUAL DISEASE | POLYMERASE-CHAIN-REACTION | ONCOLOGY | CYTOGENETIC RESPONSE | CHROMOSOMAL-ABNORMALITIES | INTERFERON-ALPHA THERAPY | MESYLATE THERAPY | Prognosis | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polymerase Chain Reaction - methods | Neoplasm Staging - methods | Young Adult | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Adult | Female | Neoplasm Staging - economics | Retrospective Studies | Chemotherapy, Adjuvant | Monitoring, Physiologic - economics | Hematologic Tests - methods | Drug Administration Schedule | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood | Cytogenetic Analysis - methods | Piperazines - therapeutic use | Imatinib Mesylate | Pyrimidines - therapeutic use | Adolescent | Cytogenetic Analysis - economics | Monitoring, Physiologic - methods | Aged | Benzamides | Polymerase chain reaction | Care and treatment | Usage | Patient outcomes | Blood monitors | Chronic myeloid leukemia | Research | In situ hybridization | Index Medicus | Abridged Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 09/2003, Volume 17, Issue 9, pp. 1687 - 1694
A significant proportion of chronic myeloid leukemia (CML) patients achieve a major cytogenetic remission (MCR) to imatinib therapy after failing interferon... 
Chronic myelogenous leukemia | FISH | Minimal residual disease | Imatinib | Quantitative RT-PCR | Molecular cytogenetics | CYTOGENETIC RESPONSES | POSITIVE CELLS | TYROSINE KINASE | BONE-MARROW | IN-SITU HYBRIDIZATION | chronic myelogenous leukemia | imatinib | CHRONIC MYELOID-LEUKEMIA | molecular cytogenetics | POLYMERASE-CHAIN-REACTION | ONCOLOGY | quantitative RT-PCR | minimal residual disease | HEMATOLOGY | BCR-ABL TRANSCRIPTS | Prognosis | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Neoplasm Recurrence, Local - drug therapy | RNA, Messenger - analysis | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - pathology | Bone Marrow - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Neoplasm, Residual - diagnosis | Sensitivity and Specificity | Adult | Female | Interferon-alpha - therapeutic use | In Situ Hybridization, Fluorescence | Survival Rate | Piperazines - therapeutic use | Reverse Transcriptase Polymerase Chain Reaction | Imatinib Mesylate | Remission Induction | Fusion Proteins, bcr-abl - genetics | Pyrimidines - therapeutic use | Bone Marrow - pathology | RNA, Neoplasm - genetics | Neoplasm Recurrence, Local - genetics | Aged | Benzamides | Fusion Proteins, bcr-abl - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Journal Article
Journal Article